• 1. Comparative behaviour of σ-complexes in phenylation of 4-methylpyridine by benzoyl peroxide in refluxing benzene
  Simone Vidal,Jean Court,Jane-Marie Bonnier J. Chem. Soc. Perkin Trans. 2 1976 497
• 2. 713. Synthesis of 2 : 6-diamino-3-arylpyridines
  B. H. Chase,James Walker J. Chem. Soc. 1953 3548
• 3. Upon the validity of partial rate factors based on isomer distributions in the phenylation of 4-methylpyridine with benzoyl peroxide
  Simone Vidal,Jean Court,Jane-Marie Bonnier J. Chem. Soc. Perkin Trans. 2 1973 2071

Professional Introduction to 4-Methyl-3-phenylpyridine (CAS No. 19352-29-5)

4-Methyl-3-phenylpyridine, with the chemical formula C₁₁H₁₁N, is a significant heterocyclic compound that has garnered considerable attention in the field of pharmaceutical chemistry and materials science. This compound, identified by its CAS number 19352-29-5, belongs to the pyridine family, a class of nitrogen-containing aromatic compounds known for their diverse biological and chemical properties. The structural features of 4-Methyl-3-phenylpyridine, including its methyl and phenyl substituents, contribute to its unique reactivity and potential applications in synthetic chemistry.

The 4-Methyl-3-phenylpyridine structure presents a versatile platform for further functionalization, making it a valuable intermediate in the synthesis of more complex molecules. Its aromatic system allows for interactions with various biological targets, which has spurred interest in its pharmacological potential. Recent research has highlighted the compound's role in developing novel therapeutic agents, particularly in the context of neurological disorders and inflammatory conditions.

In the realm of medicinal chemistry, 4-Methyl-3-phenylpyridine has been explored as a scaffold for designing molecules with improved binding affinity and selectivity. Studies have demonstrated its utility in generating derivatives that exhibit inhibitory effects on specific enzymes and receptors. For instance, modifications at the methyl and phenyl positions have led to compounds with promising anti-inflammatory properties, targeting pathways such as COX-2 and NF-κB. These findings align with the broader trend of developing targeted therapies that minimize side effects while maximizing therapeutic efficacy.

The compound's electronic properties, influenced by its conjugated system, also make it attractive for applications beyond pharmaceuticals. In materials science, 4-Methyl-3-phenylpyridine has been investigated as a component in organic semiconductors and light-emitting diodes (OLEDs). Its ability to participate in π-stacking interactions enhances charge transport properties, making it a candidate for optimizing device performance in electronic applications. This dual functionality—pharmacological relevance and material science utility—underscores the compound's versatility.

From a synthetic chemistry perspective, 4-Methyl-3-phenylpyridine serves as a key building block for constructing more intricate molecular architectures. Researchers have leveraged its reactivity to develop novel coupling strategies, enabling the efficient synthesis of polycyclic compounds with potential bioactivity. The compound's tolerance to various reaction conditions has facilitated its incorporation into complex synthetic pathways, streamlining the production of structurally diverse libraries for high-throughput screening.

The pharmacological investigation of 4-Methyl-3-phenylpyridine has revealed intriguing interactions with biological systems. Preclinical studies have suggested that derivatives of this compound may modulate neurotransmitter release and receptor activity, offering insights into potential treatments for conditions such as depression and epilepsy. Additionally, its interaction with microsomal enzymes has been studied to assess metabolic stability, a critical factor in drug development. These studies contribute valuable data to the understanding of how structural modifications influence biological activity.

The role of 4-Methyl-3-phenylpyridine in drug discovery is further highlighted by its presence in several clinical trial candidates. While not yet approved for human use, compounds derived from this scaffold have advanced through early-stage testing, demonstrating safety profiles that warrant further investigation. The ongoing development efforts underscore the compound's significance as a pharmacophore in modern drug design.

In conclusion,4-Methyl-3-phenylpyridine (CAS No. 19352-29-5) is a multifaceted compound with broad applications across pharmaceuticals and materials science. Its unique structural features enable diverse functionalization strategies, making it a valuable intermediate in synthetic chemistry. The growing body of research on this compound highlights its potential as a therapeutic agent and a material component, reinforcing its importance in contemporary scientific endeavors.

• 38840-06-1(4-Methyl-3,3'-bipyridine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)